Mayo Clinic: Research Shows New Treatment Could Delay Cancer Progression in Patients With High-Risk Smoldering Multiple Myeloma
December 11, 2024
December 11, 2024
ROCHESTER, Minnesota, Dec. 11 (TNSres) -- The Mayo Clinic issued the following news release:
A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk SMM carries a higher likelihood of progression.
Results from a phase 3 clinical trial, published in the New England Journal of Medicine and presented at this week's American Soc . . .
A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk SMM carries a higher likelihood of progression.
Results from a phase 3 clinical trial, published in the New England Journal of Medicine and presented at this week's American Soc . . .